dr. David J Mazzo
Chief Executive Officer and a Director
Cardiology
pSivida
United States of America
Biography
Dr. Mazzo is the Chief Executive Officer and a Director at Caladrius Biosciences. Prior to joining Caladrius (formerly NeoStem), Dr. Mazzo served as Chief Executive Officer and as Director of Regado Biosciences, a company focused on the development of novel anti-thrombotic drug systems for acute and sub-acute cardiovascular indications. Dr.Mazzo was also Chief Executive Officer and Director of Aeterna Zentaris, Inc. and Chief Executive Officer and Director at Chugai Pharma USA LLC, a biopharmaceutical company. Dr. Mazzo has also held senior management and executive positions in research and development and was a Director of the Essex Chimie European subsidiary at Schering-Plough Corporation. Dr. Mazzo earned a B.A. in the Honors Program (Interdisciplinary Humanities) and a B.S. in Chemistry from Villanova University. In addition, Dr. Mazzo received his M.S. in Chemistry and his Ph.D. in Analytical Chemistry from the University of Massachusetts, Amherst.
Research Interest
Cardiology.
